2019
DOI: 10.1101/827485
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Optimizing DNA extraction methods for Nanopore sequencing of Neisseria gonorrhoeae direct from urine samples

Abstract: 20 2 Oxfordshire Sexual Health Service, Oxford University Hospitals NHS Foundation Trust, 21 Oxford, UK g 22 Brighton and Hove sexual health and contraception service, Royal Sussex County Hospital, 23 Brighton, UK h 24 25 26 Running title: Nanopore sequencing N. gonorrhoeae direct from urine 27 Address correspondence to teresa.street@ndm.ox.ac.uk and david.eyre@bdi.ox.ac.uk. 28 3 Abstract 29Background. Empirical gonorrhoea treatment at initial diagnosis reduces onward 30 transmission. However, increasing resis… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2021
2021

Publication Types

Select...
2
1

Relationship

3
0

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 23 publications
0
3
0
Order By: Relevance
“…Clinical metagenomic (CMg) using nanopore technology has potential to meet these needs due to its unbiased pan-microbial coverage (18,19) and ability to provide real-time data acquisition and analysis (20). It has been evaluated for respiratory, urinary tract and prosthetic joint infections (20)(21)(22)(23), however, the full clinical potential required for laboratories and clinical teams to change their long-standing practice has not been demonstrated. We therefore prospectively assessed whether CMg testing of respiratory samples from COVID- 19 patients with suspected secondary bacterial or fungal pneumonia, could significantly improve their initial antimicrobial treatment and detect outbreaks affecting a large COVID-19 patient cohort across 7 ICUs.…”
Section: Introductionmentioning
confidence: 99%
“…Clinical metagenomic (CMg) using nanopore technology has potential to meet these needs due to its unbiased pan-microbial coverage (18,19) and ability to provide real-time data acquisition and analysis (20). It has been evaluated for respiratory, urinary tract and prosthetic joint infections (20)(21)(22)(23), however, the full clinical potential required for laboratories and clinical teams to change their long-standing practice has not been demonstrated. We therefore prospectively assessed whether CMg testing of respiratory samples from COVID- 19 patients with suspected secondary bacterial or fungal pneumonia, could significantly improve their initial antimicrobial treatment and detect outbreaks affecting a large COVID-19 patient cohort across 7 ICUs.…”
Section: Introductionmentioning
confidence: 99%
“…10,12,13 In addition, we also tested our final algorithm on 10 nanopore metagenomic sequences from N. gonorrhoeae positive urine samples obtained from men with symptomatic urethral gonorrhoea, described previously. 2 Cultured isolates from the same infections were sequenced with an Illumina MiniSeq, following the manufacturer's instructions, to allow for comparisons.…”
Section: Data Sourcesmentioning
confidence: 99%
“…1 We have recently described that rapid long-read sequencing using the Oxford Nanopore Technologies (ONT, Oxford, UK) R9.4.1 platform offers the potential to detect and sequence near-complete N. gonorrhoeae genomes directly from urine samples. 2 This clinical metagenomic approach has the advantage that it does not require prior bacterial culture, which typically adds 2-3 days to diagnostic workflows and may not be available in all cases, particularly in settings where diagnostics are based on molecular testing alone. With analysis possible during sequencing, 3 it could potentially offer a same day diagnostic tool for gonorrhoea infection that can guide antimicrobial treatment.…”
Section: Introductionmentioning
confidence: 99%